Biomerica (BMRA) Shares Outstanding (Weighted Average) (2010 - 2026)

Biomerica has disclosed Shares Outstanding (Weighted Average) across 17 years of filings, most recently posting $3.0 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $3.0 million, up 25.52% year-over-year; the trailing twelve-month figure through Feb 2026 was $3.0 million (up 25.52% YoY), and the FY2025 annual result was $2.3 million, up 9.22% from the prior year.
• Shares Outstanding (Weighted Average) came in at $3.0 million for Q1 2026 at Biomerica, up from $2.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $16.8 million in Q3 2023 to a low of $2.1 million in Q2 2024.
• The 5-year median for Shares Outstanding (Weighted Average) is $12.6 million (2022), against an average of $8.8 million.
• Across the five-year window, Shares Outstanding (Weighted Average) plunged 87.5% in 2024 and soared 30.77% in 2025, its largest moves.
• Biomerica's Shares Outstanding (Weighted Average) stood at $13.3 million in 2022, then advanced by 26.75% to $16.8 million in 2023, then slumped by 87.39% to $2.1 million in 2024, then soared by 30.77% to $2.8 million in 2025, then grew by 8.51% to $3.0 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $3.0 million (Q1 2026), $2.8 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.